JP2024545117A - 脂肪酸欠乏症の治療および予防に関する方法および組成物 - Google Patents
脂肪酸欠乏症の治療および予防に関する方法および組成物 Download PDFInfo
- Publication number
- JP2024545117A JP2024545117A JP2024534199A JP2024534199A JP2024545117A JP 2024545117 A JP2024545117 A JP 2024545117A JP 2024534199 A JP2024534199 A JP 2024534199A JP 2024534199 A JP2024534199 A JP 2024534199A JP 2024545117 A JP2024545117 A JP 2024545117A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- fatty acids
- less
- omega
- aspects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Pediatric Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163287564P | 2021-12-09 | 2021-12-09 | |
| US63/287,564 | 2021-12-09 | ||
| PCT/US2022/052076 WO2023107527A1 (en) | 2021-12-09 | 2022-12-07 | Methods and compositions relating to treatment and prevention of fatty acid deficiencies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024545117A true JP2024545117A (ja) | 2024-12-05 |
| JP2024545117A5 JP2024545117A5 (https=) | 2025-11-13 |
Family
ID=86731142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534199A Pending JP2024545117A (ja) | 2021-12-09 | 2022-12-07 | 脂肪酸欠乏症の治療および予防に関する方法および組成物 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4444110A4 (https=) |
| JP (1) | JP2024545117A (https=) |
| CN (1) | CN118678891A (https=) |
| AU (1) | AU2022406916A1 (https=) |
| CA (1) | CA3239875A1 (https=) |
| WO (1) | WO2023107527A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026060283A1 (en) * | 2024-09-13 | 2026-03-19 | Baxter International Inc. | Lipid emulsions for parenteral nutrition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008027991A2 (en) * | 2006-08-29 | 2008-03-06 | Martek Biosciences Corporation | USE OF DPA(n-6) OILS IN INFANT FORMULA |
| WO2016040570A2 (en) * | 2014-09-12 | 2016-03-17 | Children's Medical Center Corporation | Dietary emulsion formulations and methods for using the same |
-
2022
- 2022-12-07 WO PCT/US2022/052076 patent/WO2023107527A1/en not_active Ceased
- 2022-12-07 AU AU2022406916A patent/AU2022406916A1/en active Pending
- 2022-12-07 CA CA3239875A patent/CA3239875A1/en active Pending
- 2022-12-07 CN CN202280091374.1A patent/CN118678891A/zh active Pending
- 2022-12-07 EP EP22905060.4A patent/EP4444110A4/en active Pending
- 2022-12-07 JP JP2024534199A patent/JP2024545117A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4444110A4 (en) | 2025-05-14 |
| CN118678891A (zh) | 2024-09-20 |
| CA3239875A1 (en) | 2023-06-15 |
| WO2023107527A1 (en) | 2023-06-15 |
| AU2022406916A1 (en) | 2024-07-04 |
| EP4444110A1 (en) | 2024-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102088978B (zh) | 血脂异常症的改善或治疗药 | |
| US20220226238A1 (en) | Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids | |
| JP2025186415A (ja) | 非経口栄養製剤 | |
| JP2024545117A (ja) | 脂肪酸欠乏症の治療および予防に関する方法および組成物 | |
| JP2023518822A (ja) | pH依存的再構築が可能な医薬キャリア、その製造方法及び使用方法 | |
| US20250009657A1 (en) | Lipid emulsions for parenteral nutrition | |
| US20060188529A1 (en) | Stable compositions of fenofibrate with fatty acid esters | |
| JP2010229099A (ja) | 脂質異常症の改善または治療薬 | |
| JP2025529244A (ja) | 完全非経腸栄養及び経腸栄養のための抗炎症効果を有する脂質エマルション | |
| WO2020259493A1 (en) | Compositions and methods for the prevention or treatment, or dietary management of nafld | |
| RU2783166C2 (ru) | Способы и композиции, относящиеся к эмульсиям, содержащим рыбий жир и/или омега-3 жирные кислоты | |
| RU2783166C9 (ru) | Способы и композиции, относящиеся к эмульсиям, содержащим рыбий жир и/или омега-3 жирные кислоты | |
| HK40023767B (en) | Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids | |
| HK40023767A (en) | Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids | |
| BR112020002638B1 (pt) | Métodos e composições relativas a emulsões compreendendo óleo de peixe e/ou ácidos graxos ômega-3 | |
| EP3579829B1 (en) | Long-term efficacy of liver disease treatment with epa and dha | |
| HK40022806A (en) | Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251105 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251105 |